BDNF mimetics are well tolerated in mammalian models, demonstrate efficacy in rodent models of Alzheimer’s, Parkinson’s and Huntington’s disease and no adverse outcomes are reported for humans consuming 7,8 dihydroxyflavone as a nootropic supplement. This evidence concerns the gene BDNF and Parkinson disease.